There are many differences between a vaccine and transfer factor. While a vaccine exposes your body to a compromised foreign invader to trick your immune system into developing a immune response to the particular threat, it does not educate and instruct your immune system to recognize and respond accurately against broad spectrum of potential threats. A vaccine contains a number of other potentially harmful ingredients. Transfer factor is a molecule that our bodies naturally make based on our exposure to threats. By extracting transfer factors from colostrum and egg yolks, we transfer the more mature immune experience of the cow and the chicken who eat off the ground and are therefore exposed to more threats. Transfer factors improve our immune response by better educating our immune system to recognize, respond to, and remember potential threats.
4 Life™ News Brief:
Independent Bio-Assay Overview
December 11, 1998
Salt Lake City, UT - 4Life
Research, a Provo, Utah research and development company released its latest
and testing for its new 4Life Transfer Factor™ product.
Transfer factor is
a scientifically recognized delivery system for transferring immune system
advantages from one
species to another. In the patented process licensed to 4Life,
immune factors are generated in cows and then
"transferred" as a nutritional supplement to humans.
Products manufactured incorporating the process are
anticipated by industry experts to be the "next wave"
of nutritional supplementation, operating in the newly defined
area of "structure/function" claims. Dr. William
Hennen, who is one of the world authorities on transfer
of the science and technology: "Transfer
factor is a material that has
the ability to modulate the immune system.
4Life Transfer Factor™ contains both materials that help the
immune system respond more effectively and materials
to make sure the immune system is not over-responding."
4Life's founder and president, David Lisonbee said, "4Life
has an agreement with the patent inventors to market
United States Patent No. 4,816,563, issued on March 28, 1989, is licensed to
4Life. This patent
describes the proprietary process used by 4Life to create its
unique Transfer Factor™.
The only patent 4Life is aware of which identifies transfer
factor in colostrum, the process for obtaining transfer
factor from colostrum and whey, and the patented method "to
further concentrate and/or purify transfer factor" from
colostrum, is the one licensed to 4Life. It is United States
Patent No. 4,816,563.
Laboratory Testing of 4Life's Transfer Factor™
According to William Hennen, Ph.D., Vice President of Research
and Development at 4Life, "Each and every batch
of Transfer Factor™ is tested by an independent laboratory
with established, documented credentials in assessing
for transfer factor activity. Very few laboratories have the
experience or credentials to assay for TF activity. We go
to great lengths to assure the quality of transfer factor in our
product. This is the reason our distributors are
consistently having such great success with Transfer Factor™.
From infants to the elderly, reports keep coming in
every day with results that have matched or exceeded our every
expectation. Transfer factor has nearly 50 years of
research and over 3,000 clinical studies and scientific papers
proving its existence and effectiveness. Our licensed
patent proved for the first time that transfer factor exists in
colostrum and that it can be successfully extracted and
Independent Laboratories Show Transfer Factor Activity in
4Life's Transfer Factor™
Independent laboratory tests clearly indicate that 4Life's
Transfer Factor™ shows significant transfer factor activity equal to
the effectiveness of the standard vaccine.
The biological and chemical testing laboratory, BioLogics Inc.
states the following regarding 4Life's Transfer Factor™:
"BioLogics Inc. has completed testing the preparations of
bovine colostrum you sent for evaluation for TF (transfer factor)
activity. Each preparation was evaluated for TF activity using a
mouse foot- pad assay which measures delayed-type
hypersensitivity (DTH). The results are shown below. A
preparation was considered active if it induced significant DTH
(p<0.005 or better) as compared to the response to [an]
antigen in control mice which were naive (not treated with TF)."
Preparation tested Transfer Factor Transfer Factor
Vaccinated Controls 0.01>P>0.001 YES (P<0.01) Very
Mice injected with standard
Colostrum Fraction 0.20>P>0.10 NO (P>0.10) Failed
Normally fractionated colostrum
4Life Transfer Factor™ 0.01>P>0.001 YES (P<0.01) Very
Patented extract of colostrum
"Further, it is critical to understand that a proper
transfer factor assay includes both a zero-point standard and a high-end
standard (to set the span of the scale.) The zero-point standard
accounts for the nutritional value of the transfer factor
preparation and is represented by the fractionated colostrum
listed in the second row above. A vaccinated control is the
GOLD STANDARD for establishing the high-end of the immunological
scale as represented in the first row.
As was clearly shown, 4Life's Transfer Factor™ was not only
measurably more potent than the normal colostrum of the
second row, it was equal to the vaccine standard in causing a
strong immune response," stated Dr. Hennen.
Top Transfer Factor Researcher Tests 4Life's Transfer Factor™
One of the world's leading TF researchers has also tested
4Life's Transfer Factor™ using a mouse foot-pad assay.
"Three different colostrum extracts were tested, one of
which was 4Life's Transfer Factor™. 4Life's Transfer Factor™ tested
highest in TF activity of any of the samples tested."
Molecular Weight Laboratory Testing of 4Life's Transfer Factor™
An independent laboratory experienced in molecular weight
analysis tested samples of 4Life's Transfer Factor™ and found it
to contain exactly what 4Life claims it contains: Molecules in
the molecular weight of 10,000 daltons or less. Bay
Bioanalytical Laboratory, Inc. stated in their report:
"[We] have reviewed the analysis of [4Life's] Transfer
Factor performed in our laboratory using HPLC and a size exclusion
column coupled with a light scattering, refractive index and a
UV detector. Based on our analysis we can conclude [that] the
analyzed fraction is composed primarily of molecules below
10,000 [daltons] molecular weight."
Bay Bioanalytical Laboratory, Inc.